Overview
Ushio Yonezawa practices in Hiroshima, Japan. Yonezawa is rated as an Advanced expert by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). Their top areas of expertise are Dysembryoplastic Neuroepithelial Tumors (DNET), Brain Tumor, Gliomatosis Cerebri, and Glioma.
Their clinical research consists of co-authoring 39 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Dysembryoplastic Neuroepithelial Tumors (DNET).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Brain TumorYonezawa isAdvanced. Learn about Brain Tumor.
- Dysembryoplastic Neuroepithelial Tumors (DNET)
- Gliomatosis CerebriYonezawa isAdvanced. Learn about Gliomatosis Cerebri.
- Experienced
- AstrocytomaYonezawa isExperienced. Learn about Astrocytoma.
- Brain Stem CancerYonezawa isExperienced. Learn about Brain Stem Cancer.
- Cerebral Ventricle CancerYonezawa isExperienced. Learn about Cerebral Ventricle Cancer.
- Diffuse Midline Glioma H3 K27M-Mutant
- EpendymomaYonezawa isExperienced. Learn about Ependymoma.
- FibrosarcomaYonezawa isExperienced. Learn about Fibrosarcoma.